Anfield Capital Management, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1602020
IRVINE, CA
Position in TEVA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,198
-$80 QoQ
Shares Held
73
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Anfield Capital Management, LLC holds $9,625 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (22.8% of the industry book) .
All Filings in TEVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,198 | 73 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,278 | 73 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $1,474 | 73 | Shares | Defined | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||